News & Press: Press

ISCT Featured in The Wall Street Journal

Monday, August 28, 2017  
Share |

 

ISCT leader Bill Milligan, Chair of the Business Models and Cost of Goods Subcommittee speaks on behalf of ISCT to the Wall Street Journal.

August 28 - The Promising New Cancer Treatment Behind Gilead's $11 Billion Deal. Read the Article


© 2017 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.